The crystal structure of a TL/CD8αα complex at 2.1 Å resolution: Implications for modulation of T cell activation and memory

Immunity

Volumn 18, Issue 2, 2003, Pages 205-215

  Liu, Yiwei ^a   Xiong, Yi ^a   Naidenko, Olga V ^b,d   Liu, Jin Huan ^a   Zhang, Rongguang ^c   Joachimiak, Andrzej ^c   Kronenberg, Mitchell ^b   Cheroutre, Hilde ^b   Reinherz, Ellis L ^a   Wang, Jia Huai ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c ARGONNE NATIONAL LABORATORY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; X RAY CRYSTALLOGRAPHY;

EID: 0037331174     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00027-X     Document Type: Article

References (59)

1. Aldrich C.J., DeCloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell. 79:1994;649-658.
2. Arcaro A., Gregoire C., Bakker T.R., Baldi L., Jordan M., Goffin L., Boucheron N., Wurm F., van der Merwe P.A., Malissen B.et al. CD8β endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J. Exp. Med. 194:2001;148-195.
3. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature. 329:1987;512-518.
4. Bouvier M., Wiley D.C. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science. 265:1994;398-402.
5. Braud V., Jones E.Y., McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27:1997;1164-1169.
6. Braud V.M., Allan D.S., McMichael A.J. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11:1999;100-108.
7. Brunger A., Adams P., Clore G., DeLano W., Gros P., Grosse-Kunstleve R., Jiang J.-S., Kuszewski J., Nilges N., Pannu N.et al. Crystallography & NMR system (CNS). a new software system for macromolecular structure determination Acta Crystallogr. D. 54:1998;905-921.
8. Burmeister W.P., Huber A.H., Bjorkman P.J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature. 372:1994;379-383.
9. CCP4 Collaborative Computational Project 4) The CCP4 suite. programs for protein crystallography Acta Crystallogr. D. 50:1994;760-763.
10. Chen Y.T., Obata Y., Stockert E., Old L.J. Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. J. Exp. Med. 162:1985;1134-1148.
11. Cheroutre H., Holcombe H., Tangri S., Castano A.R., Teitell M., Miller J.E., Cardell S., Benoist C., Mathis D., Huse W.D.et al. Antigen-presenting function of the TL antigen and mouse CD1 molecules. Immunol. Rev. 147:1995;31-52.
12. Crowley M.P., Reich Z., Mavaddat N., Altman J.D., Chien Y. The recognition of the nonclassical major histocompatibility complex (MHC) class I molecule, T10, by the gammadelta T cell, G8. J. Exp. Med. 185:1997;1223-1230.
13. Devine L., Rogozinski L., Naidenko O.V., Cheroutre H., Kavathas P.B. The complementarity-determining region-like loops of CD8 alpha interact differently with beta 2-microglobulin of the class I molecules H-2Kb and thymic leukemia antigen, while similarly with their alpha 3 domains. J. Immunol. 168:2002;3881-3886.
14. Feder J.N., Penny D.M., Irrinki A., Lee V.K., Lebron J.A., Watson N., Tsuchihashi Z., Sigal E., Bjorkman P.J., Schatzman R.C. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. USA. 95:1998;1472-1477.
15. Gadola S.D., Zaccai N.R., Harlos K., Shepherd D., Castro-Palomino J.C., Ritter G., Schmidt R.R., Jones E.Y., Cerundolo V. Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat. Immunol. 3:2002;721-726.
16. Gao G.F., Tormo J., Gerth U.C., Wyer J.R., McMichael A.J., Stuart D.I., Bell J.I., Jones E.Y., Jakobsen B.K. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature. 387:1997;630-634.
17. Garcia K.C., Degano M., Stanfield R.L., Brunmark A., Jackson M.R., Peterson P.A., Teyton L., Wilson I.A. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.
18. Garcia K.C., Teyton L., Wilson I.A. Structural basis of T cell recognition. Annu. Rev. Immunol. 17:1999;369-397.
19. He X., Tabaczewski P., Ho J., Stroynowski I., Garcia K.C. Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation. Structure (Camb). 9:2001;1213-1224.
20. Holcombe H., Castano A.R., Cheroutre H., Teitell M., Maher J.K., Peterson P.A., Kronenberg M. Nonclassical behavior of the thymus leukemia antigen. peptide transporter-independent expression of a nonclassical class I molecule J. Exp. Med. 181:1995;1433-1443.
21. Jones T.A., Zou J.-Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
22. Kern P.S., Teng M.-K., Smolyar A., Liu J.-H., Liu J., Hessey R.E., Spoerl R., Chang H.-C., Reinherz E.L., Wang J.-H. Structural basis of CD8 co-receptor function revealed by crystallographic analysis of a murine CD8αα ectodomain fragment in complex with H-2Kb. Immunity. 9:1998;519-530.
23. Konno A., Okada K., Mizuno K., Nishida M., Nagaoki S., Toma T., Uehara T., Ohta K., Kasahara Y., Seki H.et al. CD8alpha alpha memory effector T cells descend directly from clonally expanded CD8alpha +beta high TCRalpha beta T cells in vivo. Blood. 100:2002;4090-4097.
24. Krulis P. Molscript. a program to produce both detailed and schematic plots J. Appl. Crystallogr. 24:1991;924-950.
25. Ku C.C., Murakami M., Sakamoto A., Kappler J., Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science. 288:2000;675-678.
26. Kulski J.K., Dunn D.S., Gaudieri S., Shiina T., Inoko H. Genomic and phylogenetic analysis of the human CD1 and HLA class I multicopy genes. J. Mol. Evol. 53:2001;642-650.
27. Lebron J.A., Bennett M.J., Vaughn D.E., Chirino A.J., Snow P.M., Mintier G.A., Feder J.N., Bjorkman P.J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell. 93:1998;111-123.
28. Leishman A.J., Naidenko O.V., Attinger A., Koning F., Lena C.J., Xiong Y., Chang H.C., Reinherz E., Kronenberg M., Cheroutre H. T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule. TL. Science. 294:2001;1936-1939.
29. Li P., Willie S.T., Bauer S., Morris D.L., Spies T., Strong R.K. Crystal structure of the MHC class I homolog MIC-A, a γδ T cell ligand. Immunity. 10:1999;577-584.
30. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 9:1998;669-676.
31. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:1995;587-622.
32. Mashimo H., Chorney M.J., Pontarotti P., Fisher D.A., Hood L., Nathenson S.G. Nucleotide sequence of the BALB/c H-2T region gene, T3d. Immunogenetics. 36:1992;326-332.
33. Matsumura M., Fremont D.H., Peterson P.A., Wilson I.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science. 257:1992;927-934.
34. Molina T.J., Kishihara K., Siderovski D.P., van Ewijk W., Narendran A., Timms E., Wakeham A., Paige C.J., Hartmann K.U., Veillette A.et al. Profound block in thymocyte development in mice lacking p56lck. Nature. 357:1992;161-164.
35. Moody A.M., Xiong Y., Chang H.C., Reinherz E.L. The CD8alphabeta co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci. Eur. J. Immunol. 31:2001;2791-2799.
36. Nicholls A., Sharp K.A., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins. 11:1991;281-296.
37. Obata Y., Satta Y., Moriwaki K., Shiroishi T., Hasegawa H., Takahashi T., Takahata N. Structure, function, and evolution of mouse TL genes, nonclassical class I genes of the major histocompatibility complex. Proc. Natl. Acad. Sci. USA. 91:1994;6589-6593.
38. Old L.J., Boyse E.A., Stockert E. Antigenic properties of experimental leukemias. I. Serological studies in vitro with spontaneous and radiation-induced leukemias. J. Natl. Cancer Inst. 31:1963;977.
39. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Carte C.W. Jr., Sweet R.M. Macromolecular Crystallography. 1997;Academic Press, San Diego. 307-326.pp.
40. Pontarotti P.A., Mashimo H., Zeff R.A., Fisher D.A., Hood L., Mellor A., Flavell R.A., Nathenson S.G. Conservation and diversity in the class I genes of the major histocompatibility complex. sequence analysis of a Tlab gene and comparison with a Tlac gene Proc. Natl. Acad. Sci. USA. 83:1986;1782-1786.
41. Rodgers J.R., Mehta V., Cook R.G. Surface expression of β2 microglobulin-associated thymus-leukemia antigen is independent of TAP2. Eur. J. Immunol. 25:1995;1001-1007.
42. Sanchez L.M., Chirino A.J., Bjorkman P. Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules. Science. 283:1999;1914-1919.
43. Schild H., Mavaddat N., Litzenberger C., Ehrich E.W., Davis M.M., Bluestone J.A., Matis L., Draper R.K., Chien Y.H. The nature of major histocompatibility complex recognition by gamma delta T cells. Cell. 76:1994;29-37.
44. Sharma P., Joyce S., Chorney K.A., Griffith J.W., Bonneau R.H., Wilson F.D., Johnson C.A., Flavell R.A., Chorney M.J. Thymus-leukemia antigen interacts with T cells and self-peptides. J. Immunol. 156:1996;987-996.
45. Shawar S.M., Vyas J.M., Rodgers J.R., Rich R.R. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:1994;839-880.
46. Straus D.B., Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 21:1992;585-593.
47. Stroynowski I., Lindahl K.F. Antigen presentation by non-classical class I molecules. Curr. Opin. Immunol. 6:1994;38-44.
48. Suzuki H., Duncan G.S., Takimoto H., Mak T.W. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J. Exp. Med. 185:1997;499-505.
49. Teitell M., Mescher M.F., Olson C.A., Littman D.R., Kronenberg M. The thymus leukemia antigen binds human and mouse CD8. J. Exp. Med. 174:1991;1131-1138.
50. Teitell M., Holcombe H., Cheroutre H., Aldrich C.J., Stroynowski I., Forman J., Kronenberg M. The alpha 3 domain of the Qa-2 molecule is defective for CD8 binding and cytotoxic T lymphocyte activation. J. Exp. Med. 178:1993;2139-2145.
51. Teitell M., Cheroutre H., Panwala C., Holcombe H., Eghtesady P., Kronenberg M. Structure and function of H-2 T (Tla) region class I MHC molecules. Crit. Rev. Immunol. 14:1994;1-27.
52. Turner J.M., Brodsky M.H., Irving B.A., Levin S.D., Perlmutter R.M., Littman D.R. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell. 60:1990;755-765.
53. Wang C.R., Castano A.R., Peterson P.A., Slaughter C., Lindahl K.F., Deisenhofer J. Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell. 82:1995;655-664.
54. Wang J.-H., Meijers R., Xiong Y., Liu J.-H., Sakihama T., Zhang R., Joachimiak A., Reinherz E. Crystal structure of the human CD4 N-terminal two domain fragment complexed to a class II MHC molecule. Proc. Natl. Acad. Sci. USA. 98:2001;10799-10804.
55. Weber D.A., Attinger A., Kemball C.C., Wigal J.L., Pohl J., Xiong Y., Reinherz E.L., Cheroutre H., Kronenberg M., Jensen P.E. Peptide-independent folding and CD8alphaalpha binding by the nonclassical class I molecule, thymic leukemia antigen. J. Immunol. 169:2002;5708-5714.
56. Weintraub B.C., Jackson M.R., Hedrick S.M. Gamma delta T cells can recognize nonclassical MHC in the absence of conventional antigenic peptides. J. Immunol. 153:1994;3051-3058.
57. Wingren C., Crowley M.P., Degano M., Chien Y., Wilson I.A. Crystal structure of a gammadelta T cell receptor ligand T22. a truncated MHC-like fold Science. 287:2000;310-314.
58. Yao L., Nakauchi H., Honjo T., Kawakami T. The cytoplasmic domain of the CD8α chain is required for its interaction with p56lck. Immunol. Lett. 24:1990;267-271.
59. Zeng Z., Castano A.R., Segelke B.W., Stura E.A., Peterson P.A., Wilson I.A. Crystal structure of mouse CD1. an MHC-like fold with a large hydrophobic binding groove Science. 277:1997;339-345.